Multisite study of the safety and efficacy of LumenHance, a new gastrointestinal contrast agent for MRI of the abdomen and pelvis (Q74483527)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9561066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Multisite study of the safety and efficacy of LumenHance, a new gastrointestinal contrast agent for MRI of the abdomen and pelvis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9561066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

W C Small

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9561066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

D D Macchi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9561066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

J R Parker

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9561066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

M E Bernardino

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9561066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 April 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9561066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9561066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

5 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9561066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

S147-50; discussion S156

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9561066%20AND%20SRC:MED&resulttype=core&format=json

Magnetite albumin suspension: a superparamagnetic oral MR contrast agent

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2898%2980087-1

7 January 2021

Perfluorochemicals as gastrointestinal contrast agents for MR imaging: preliminary studies in rats and humans

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2898%2980087-1

7 January 2021

MR imaging of the gastrointestinal tract: value of Gd-DTPA

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2898%2980087-1

7 January 2021

First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2898%2980087-1

7 January 2021

Barium sulfate suspension as a negative oral MRI contrast agent: in vitro and human optimization studies

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2898%2980087-1

7 January 2021

Comparison of Kaopectate with barium for negative and positive enteric contrast at MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2898%2980087-1

7 January 2021

Perfluoroctylbromide as a gastrointestinal contrast agent for MR imaging: use with and without glucagon.

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2898%2980087-1

7 January 2021

Gd-DTPA as an intestinal contrast agent for MR imaging of the lower abdomen: phase III clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2898%2980087-1

7 January 2021

Phase III trial of oral magnetic particles in MRI of abdomen and pelvis

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2898%2980087-1

7 January 2021

Use of AMI-227 as an oral MR contrast agent

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2898%2980087-1

7 January 2021

Perflubron as an oral contrast agent for MR imaging: results of a phase III clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2898%2980087-1

7 January 2021

Nuclear magnetic resonance contrast enhancement study of the gastrointestinal tract of rats and a human volunteer using nontoxic oral iron solutions

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2898%2980087-1

7 January 2021

Work in progress: potential oral and intravenous paramagnetic NMR contrast agents

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2898%2980087-1

7 January 2021

Safety and optimum concentration of a manganese chloride-based oral MR contrast agent

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2898%2980087-1

7 January 2021

10.1016/S1076-6332(98)80087-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9561066%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference